Evidence map›Paper›PMID 27222028›Full record

ArticleVirulence2016

Pathophysiological mechanisms of diarrhea caused by the Vibrio cholerae O1 El Tor variant: an in vivo study in mice.

Saravut Satitsri, Pawin Pongkorpsakol, Potjanee Srimanote, Varanuj Chatsudthipong, Chatchai Muanprasat

Open access · goldAbstract read
In one paragraph

Article in Virulence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Diarrhea management: from pathophysiology to microbiota modulation.Therapeutic advances in gastroenterology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Evaluation ofHeliyon · 2023
    Article
  8. Review
  9. Maren Pills Improve Constipation via Regulating AQP3 and NF-Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
  10. Article
  11. Eicosanoids in the gastrointestinal tract.British journal of pharmacology · 2019
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Saravut Satitsria Department of Physiology , Faculty of Science, Mahidol University , Ratchathewi , Bangkok , Thailand.
Pawin Pongkorpsakolb Graduate Program in Translational Medicine, Research Center, Faculty of Medicine, Ramathibodi Hospital, Mahidol University , Ratchathewi , Bangkok , Thailand.
Potjanee Srimanotec Graduate Studies, Faculty of Allied Health Science, Thammasat University , Rangsit , Prathumthani , Thailand.
Varanuj Chatsudthiponga Department of Physiology , Faculty of Science, Mahidol University , Ratchathewi , Bangkok , Thailand.
Chatchai Muanprasata Department of Physiology , Faculty of Science, Mahidol University , Ratchathewi , Bangkok , Thailand.
Mahidol University · THMinistry of Education · THThammasat University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholera is caused by infection with Vibrio cholerae. This study aimed to investigate the pathophysiology of diarrhea caused by the V. cholerae O1 El Tor variant (EL), a major epidemic strain causing severe diarrhea in several regions. In the ligated ileal loop model of EL-induced diarrhea in the ICR mice, a cystic fibrosis transmembrane conductance regulator (CFTR) inhibitor and a calcium-activated chloride channel (CaCC) inhibitor similarly inhibited intestinal fluid secretion. In addition, barrier disruption and NF-κB-mediated inflammatory responses, e.g., iNOS and COX-2 expression, were observed in the infected ileal loops. Interestingly, intestinal fluid secretion and barrier disruption were suppressed by NF-κB and COX-2 inhibitors, whereas an iNOS inhibitor suppressed barrier disruption without affecting fluid secretion. Furthermore, EP2 and EP4 PGE2 receptor antagonists ameliorated the fluid secretion in the infected ileal loops. The amount of cholera toxin (CT) produced in the ileal loops by the EL was ∼2.4-fold of the classical biotype. The CT transcription inhibitor virstatin, a toll-like receptor-4 (TLR-4) antibody and a CT antibody suppressed the EL-induced intestinal fluid secretion, barrier disruption and COX-2 expression. The CT at levels detected during EL infection induced mild intestinal barrier disruption without inducing inflammatory responses in mouse intestine. Collectively, this study indicates that CT-induced intestinal barrier disruption and subsequent TLR-4-NF-κB-mediated COX-2 expression are involved in the pathogenesis of EL-induced diarrhea and represent promising novel therapeutic targets of cholera.

Indexed as

AnimalsBacterial Typing TechniquesButyratesChloride ChannelsCholeraCholera ToxinCyclooxygenase 2DiarrheaDinoprostoneDisease Models, AnimalEnteritisGenetic VariationGenotypeIntestinesMiceMice, Inbred CFTRButyratesChloride ChannelsCholera ToxinCyclooxygenase 2DinoprostoneNaphthalimidesNitric Oxide Synthase Type IINos2 protein, mousePtgs2 protein, mousevirstatinCFTRcholeradiarrheaEl Tor variantinflammationPGE2Vibrio cholera

Identifiers

PMID27222028
PMCPMC5029298
OpenAlexW2405294062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.